Claudin-1 (CLDN1) as a new therapeutic target in colorectal cancer: Inhibition of cell growth and survival by an anti-CLDN1 monoclonal antibody

被引：1
|
作者：
Ayrolles-Torro, Adeline [1 ,2 ,3 ]
Vezzio-Vie, Nadia [1 ,2 ,3 ]
Denis, Vincent [1 ,2 ,3 ]
Boissiere-Michot, Florence [4 ]
Garambois, Veronique [1 ,2 ,3 ]
Busson, Muriel [1 ,2 ,3 ]
Arsa, Imade Ait [1 ,2 ,3 ]
Mollevi, Caroline [4 ]
Pugniere, Martine [1 ,2 ,3 ]
Bibeau, Frederic [4 ]
Martineau, Pierre [1 ,2 ,3 ]
Gongora, Celine [1 ,2 ,3 ]
Del Rio, Maguy [1 ,2 ,3 ]
机构：
[1] IRCM, Montpellier, France
[2] INSERM, U896, Montpellier, France
[3] Univ Montpellier I, Montpellier, France
[4] Inst Reg Canc Montpellier, ICM, Montpellier, France
来源：
MOLECULAR CANCER THERAPEUTICS | 2013年 / 12卷 / 11期
关键词：
D O I：
10.1158/1535-7163.TARG-13-B245
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B245
引用
收藏
页数：1
相关论文
共 50 条
  • [21] LIN28B promotes collective cell invasion and colorectal cancer metastasis via a novel CLDN1 and NOTCH3 axis.
    Shin, Alice E.
    Sugiura, Kensuke
    Masuike, Yasunori
    Suzuki, Kensuke
    Lengner, Christopher J.
    Rustgi, Anil K.
    CANCER RESEARCH, 2022, 82 (23)
  • [22] Claudin-1 is a mediator and therapeutic target of biliary fibrosis by modulating liver progenitor cell fate and signaling
    Del Zompo, Fabio
    Crouchet, Emilie
    Ostyn, Tessa
    Juhling, Frank
    Moehlin, Julien
    Roehlen, Natascha
    Andrews, Tallulah
    Nakib, Diana
    Perciani, Catia
    Chung, Sai
    Bader, Gary L.
    Mcgilvray, Ian
    MacParland, Sonya
    Iacone, Roberto
    Teixeira, Geoffrey
    Heikenwaelder, Mathias
    Govaere, Olivier
    Roskams, Tania
    Schuster, Catherine
    Mailly, Laurent
    Baumert, Thomas
    JOURNAL OF HEPATOLOGY, 2024, 80 : S31 - S32
  • [23] Anti-Prokineticin1 (PROK1) Monoclonal Antibody Suppresses Angiogenesis and Tumor Growth in Colorectal Cancer
    Takanori Goi
    Toshiyuki Nakazawa
    Yasuo Hirono
    Akio Yamaguchi
    Annals of Surgical Oncology, 2014, 21 : 665 - 671
  • [24] Anti-Prokineticin1 (PROK1) Monoclonal Antibody Suppresses Angiogenesis and Tumor Growth in Colorectal Cancer
    Goi, Takanori
    Nakazawa, Toshiyuki
    Hirono, Yasuo
    Yamaguchi, Akio
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S665 - S671
  • [25] CLDN1 Increases Drug Resistance of Non-Small Cell Lung Cancer by Activating Autophagy via Up-Regulation of ULK1 Phosphorylation
    Zhao, Zhenhuan
    Li, Jing
    Jiang, Yan
    Xu, Wen
    Li, Xin
    Jing, Weili
    MEDICAL SCIENCE MONITOR, 2017, 23 : 2906 - 2916
  • [26] CLDN18-ARHGAP26 function in gastric cancer and be a new therapeutic target by ABCG2 and ABCB1 pathway
    Li, Jing
    Zheng, Xuwei
    Jia, Jianguang
    Xie, Bo
    Zhang, Chensong
    Wang, Hu
    Li, Hongbo
    Ma, Jiachi
    FOOD SCIENCE AND TECHNOLOGY, 2022, 42
  • [27] LncRNA XIST Promotes Migration and Invasion of Papillary Thyroid Cancer Cell by Modulating MiR-101-3p/CLDN1 Axis
    Yong-Liang Du
    Yan Liang
    Yan Cao
    Le Liu
    Jian Li
    Guang-Qing Shi
    Biochemical Genetics, 2021, 59 : 437 - 452
  • [28] LncRNA XIST Promotes Migration and Invasion of Papillary Thyroid Cancer Cell by Modulating MiR-101-3p/CLDN1 Axis
    Du, Yong-Liang
    Liang, Yan
    Cao, Yan
    Liu, Le
    Li, Jian
    Shi, Guang-Qing
    BIOCHEMICAL GENETICS, 2021, 59 (02) : 437 - 452
  • [29] Claudin-1, a novel target of miR-375 in non-small cell lung cancer
    Yoda, Satoshi
    Soejima, Kenzo
    Yasuda, Hiroyuki
    Sato, Takashi
    Arai, Daisuke
    Ohgino, Keiko
    Ishioka, Kota
    Tani, Tetsuo
    Oashi, Ayano
    Kuroda, Aoi
    Nishino, Makoto
    Miyawaki, Masayoshi
    Hamamoto, Junko
    Naoki, Katsuhiko
    Betsuyaku, Tomoko
    CANCER RESEARCH, 2014, 74 (19)
  • [30] Expressions of CLDN1 and insulin-like growth factor 2 are associated with poor prognosis in stage N2 non-small cell lung cancer
    Zhang Zhen-fa
    Pei Bao-xiang
    Wang An-lei
    Zhang Lian-min
    Sun Bing-sheng
    Jiang Ri-cheng
    Wang Chang-li
    CHINESE MEDICAL JOURNAL, 2013, 126 (19) : 3668 - 3674
12345